Who is sponsoring NCT02920372?

NCT02920372 is sponsored by Parc de Salut Mar.

What drugs are being tested in NCT02920372?

Interventions in NCT02920372: EPOETIN ALFA.

What condition does NCT02920372 study?

NCT02920372 studies There Are no Conditions Under Study. Healthy Volunteers.

Is NCT02920372 still recruiting?

NCT02920372 is currently completed. Last updated 5 October 2017.

Last reviewed 2017-10-05 · How we verify

NCT02920372

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Generation of Positive Biological Samples to Epoetin for Doping Control.

Completed Phase 1 Last updated 5 October 2017

What this trial tests

Phase 1 trial testing EPOETIN ALFA in There Are no Conditions Under Study. Healthy Volunteers in 2 participants. Completed in 30 September 2017.

Timeline

30 November 2016

Primary endpoint
17 January 2017

30 September 2017

Quick facts

Lead sponsor	Parc de Salut Mar
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	2
Start date	30 November 2016
Primary completion	17 January 2017
Estimated completion	30 September 2017

Drugs / interventions tested

EPOETIN ALFA (EPOETIN ALFA) — full drug profile →

Conditions studied

There Are no Conditions Under Study. Healthy Volunteers — all drugs for There Are no Conditions Under Study. Healthy Volunteers →

Sponsor

Parc de Salut Mar — full company profile →

Who can join

Adults 18 to 50, male only, with There Are no Conditions Under Study. Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study consists of generation of biological samples (in blood and urine) positive to Epoetin alfa for laboratories that wish to perform the analysis of doping controls and maintain accreditation from World Anti-Doping Agency.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Parc de Salut Mar trials

Trials by the same sponsor.

NCT06163235 — Efficacy of a Mobile Application and Semi-attendance Program in Bariatric Surgery · NA · not yet recruiting
NCT07223450 — A Study on Oral and Intranasal Forms of Oxycodone in Healthy Volunteers Using Pharmacokinetic Modeling · Phase 1 · completed
NCT07504913 — Spanish Validation of KOQUSS-40 Questionnaire: Assessing QoL of Gastric Cancer Patients After Gastrectomy: SPQUSS-41 · recruiting
NCT06806072 — BALNEOTHERAPY FOR BREAST CANCER PATIENTS UNDERGOING ENDOCRINE THERAPY · NA · not yet recruiting
NCT04084795 — Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02920372 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Parc de Salut Mar
Last refreshed: 5 October 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02920372.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing